Rui Zeng

机构：Sichuan University, Chengdu Women's and Children's Central Hospital, State Key Laboratory of Biotherapy · ORCID：0000-0001-9716-6354

发表论文 29 篇 · 总被引 909 次 · h-index 9

代表论文

• SARS-CoV-2 M pro inhibitors with antiviral activity in a transgenic mouse model (2021 · Science · 被引 455)
• Structural characterization of the C-terminal domain of SARS-CoV-2 nucleocapsid protein (2020 · Molecular Biomedicine · 被引 124)
• An orally available Mpro inhibitor is effective against wild-type SARS-CoV-2 and variants including Omicron (2022 · Nature Microbiology · 被引 103)
• A new generation Mpro inhibitor with potent activity against SARS-CoV-2 Omicron variants (2023 · Signal Transduction and Targeted Therapy · 被引 85)
• GPR48, a poor prognostic factor, promotes tumor metastasis and activates β-catenin/TCF signaling in colorectal cancer (2013 · Carcinogenesis · 被引 46)
• Discovery and structure-activity relationship studies of novel α-ketoamide derivatives targeting the SARS-CoV-2 main protease (2023 · European Journal of Medicinal Chemistry · 被引 17)